• / Free eNewsletters & Magazine
  • / My Account
Home>Valeant posts wider loss for fourth quarter as revenue dips

Valeant posts wider loss for fourth quarter as revenue dips

3party Content

Tue, 28 Feb 2017

Valeant Pharmaceuticals International Inc. shares (VRX.T) jumped, then reversed their gains, in premarket trade Tuesday, after the company reported a fourth-quarter loss and decline in revenues, but still beat Wall Street estimates. Valeant, which was immersed in an accounting and drug pricing

©2017 Morningstar Advisor. All right reserved.